Humanity & Health

Recent papers from Humanity & Health

1. Translational Hepatology From Bedside to Global Policy: How Robust Clinical and Translational Research Reshapes Global Practice Guidelines and Patient OutcomesJournal of Gastroenterology and Hepatology · 2026
2. Neighborhood Contemporary Redlining and Racial Mortgage Lending Bias and Cardiovascular Outcomes in Women With Breast CancerJournal of the American Heart Association · 2026
3. Strategies to improve outcomes of obstetric emergencies in sub-Saharan Africa: A scoping reviewPLoS ONE · 2026
4. From emergency adaptation to institutional resilience: a policy and practice review of Somalia's health system, 1991–2026Frontiers in Health Services · 2026
5. Sierra Leone's Constitutional Crossroads: When Political Convenience Confronts the Supreme Law2026
6. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 updateHepatology International · 2026
7. Interplanetary Solar Energy Relay: Feasibility Analysis of a Mercury-Based Collection and Multi-Hop Distribution System2026
8. Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study.2026
9. HBsAg Quantification‐Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs‐Experienced Patients With Chronic Hepatitis B: The HBsAg ‐ HCC ScoreAlimentary Pharmacology & Therapeutics · 2026
10. Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across AsiaHepatology International · 2026
11. Co-Creation of Global Public Health Interventions Within the Context of Limited Resources: A Conceptual Qualitative Framework for Modest Co-CreationInternational Journal of Qualitative Methods · 2026
12. How Conceptualisation Matters for Representation: The Case of Migrantised GroupsRepresentation · 2025
13. Five-year overall survival (OS) and OS by baseline liver function from the Phase 3 HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)Zeitschrift für Gastroenterologie · 2025
14. Subsequent anticancer therapy analysis of the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinomaZeitschrift für Gastroenterologie · 2025
15. The protective effect of sodium selenite against silver nanoparticles induced oxidative stress and autophagy in cardiomyocytes is associated with AMPK/mTOR signaling pathwayNanotoxicology · 2025
16. Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysisHepatology International · 2025
17. Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trialHepatology · 2025
18. Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCCJournal of Hepatology · 2025
19. Assessing pricing and affordability of HBV treatment in Asia–Pacific region: a barrier to eliminationHepatology International · 2025
20. Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from AsiaHepatology International · 2025